Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020
Current Assets:
Cash and cash equivalents	$ 22,559	$ 31,267	$ 38,267	$ 49,216	$ 49,533	$ 31,970	$ 16,782	$ 16,229
Accounts receivable, net of allowances of $586 at March 31, 2022 and $197 at March 31, 2021	15,894	14,186	14,528	10,279	12,902	11,387	9,490	10,389
Inventories, net	30,167	31,001	29,568	27,155	21,688	21,635	21,207	24,128
Prepaid expenses and other current assets	5,519	5,158	4,310	5,718	4,953	3,752	3,663	4,778
Total current assets	74,139	81,612	86,673	92,368	89,076	68,744	51,142	55,524
Property, plant, equipment and rental assets, net	18,038	14,262	11,687	10,669	9,630	8,075	8,358	7,560
Non-current portion of inventories	1,680	1,635	1,752	1,802	1,845	1,917	1,618	1,571
Other assets	8,635	8,790	8,958	7,497	7,639	7,782	7,942	8,093
Total assets	102,492	106,299	109,070	112,336	108,190	86,518	69,060	72,748
Current Liabilities:
Accounts payable and accrued expenses	25,130	26,340	24,754	22,396	19,767	14,600	10,908	10,804
Accrued salaries and wages	1,147	1,722	1,351	1,565	1,889	1,471	1,341	1,159
Accrued warranty reserve	1,483	1,428	1,864	3,904	5,850	1,523	1,427	1,768
Deferred revenue	14,835	11,290	10,200	9,041	11,822	10,976	12,183	11,490
Current portion of notes payable and lease obligations	675	707	860	1,097	576	495	568	878
Factory protection plan liability	9,170	7,687	8,027	8,566	7,662	7,460	6,935	5,703
Term note payable	50,949	50,940	50,932	50,923
Total current liabilities	103,389	100,114	97,988	97,492	47,566	36,525	33,362	31,802
Deferred revenue, non-current	981	927	700	734	765	818	860	902
Long-term portion of notes payable and lease obligations	5,809	5,984	6,155	4,589	4,762	4,661	4,920	4,941
Term note payable, noncurrent					52,865	52,856	30,419	30,112
Total liabilities	110,179	107,025	104,843	102,815	105,958	94,860	69,561	67,757
Commitments and contingencies (Note 13)
Stockholders' (Deficiency) Equity:
Preferred stock, $.001 par value; 1,000,000 shares authorized; none issued
Common stock, $.001 par value; 51,500,000 shares authorized, 15,398,368 shares issued and 15,296,735 shares outstanding at March 31, 2022; 12,898,144 shares issued and 12,824,190 shares outstanding at March 31, 2021	15	15	15	15	13	11	11	11
Additional paid-in capital	946,969	946,621	946,278	945,918	934,381	918,683	917,674	917,439
Accumulated deficit	(952,583)	(945,284)	(939,996)	(934,434)	(930,213)	(925,118)	(916,268)	(910,580)
Treasury stock, at cost; 101,633 shares at March 31, 2022 and 73,954 shares at March 31, 2021	(2,088)	(2,078)	(2,070)	(1,978)	(1,949)	(1,918)	(1,918)	(1,879)
Total stockholders' (deficiency) equity	(7,687)	(726)	4,227	9,521	2,232	(8,342)	(501)	4,991	$ 4,449
Total liabilities and stockholders' (deficiency) equity	$ 102,492	$ 106,299	$ 109,070	$ 112,336	$ 108,190	$ 86,518	$ 69,060	$ 72,748